-
SM-164 Workflows for IAP-Targeted Apoptosis Research
2026-08-20
SM-164 is a bivalent Smac mimetic for connecting IAP degradation, TNFα signaling, and caspase-dependent death in cancer research. This practical guide combines concentration-setting, orthogonal apoptosis readouts, and a Pol II-focused assay strategy to help distinguish pathway activation from nonspecific transcriptional stress.
-
DNA Damage and Selective CUX2 Neuron Loss
2026-08-19
The reference study identifies accumulated DNA damage and insufficient repair as a mechanistic explanation for the selective vulnerability of CUX2-positive layer 2/3 excitatory neurons during neuroinflammation. By integrating human multiple sclerosis tissue, mouse inflammatory models, neuronal genetic perturbation, and interferon-γ experiments, it connects inflammatory signaling, reactive oxygen species, double-strand break repair, and cell-type-specific neuronal loss.
-
Bufalin–CRISPR Nanomedicine for Colorectal Cancer
2026-08-19
The reference study introduces a calcium lactate nanomedicine that co-delivers bufalin and a CRISPR/Cas9 ribonucleoprotein targeting CD47. By combining tumor-cell apoptosis and pyroptosis with M2-to-M1 macrophage reprogramming and enhanced phagocytosis, the platform aims to connect local cytotoxicity with systemic antitumor immunity.
-
ALDH2 Synthetic Lethality in APC-Deficient CRC
2026-08-18
Liang and colleagues report that pharmacological ALDH2 inhibition with Disulfiram selectively compromises APC-deficient colorectal cancer models. The study links this vulnerability to progressive ROS accumulation and activation of the ASK1/JNK apoptotic pathway, providing a genotype-informed framework for colorectal cancer research.
-
HA-LNP PTEN mRNA for Transdermal Melanoma Therapy
2026-08-18
The reference study develops a hyaluronate-conjugated lipid nanoparticle that delivers PTEN mRNA through the skin and targets CD44-expressing melanoma-associated cells. Its preclinical findings link localized PTEN restoration with reduced melanoma viability, immunogenic cell death, tumor growth inhibition, and enhanced antitumor immune activation.
-
gamma-Glu-Cys (γ-Glu-Cys): Workflow Guide
2026-08-17
gamma-Glu-Cys (γ-Glu-Cys), SKU B7887, provides a defined glutathione-biosynthesis intermediate for glutathione synthetase enzyme assays, pathway studies, and selected plant workflows. This guide covers preparation, storage, QC, and troubleshooting; the material is for scientific research only and is not intended for diagnostic, clinical, or therapeutic use.
-
Doxorubicin Beyond 2D: A Translational Roadmap
2026-08-17
Doxorubicin and Adriamycin remain powerful translational benchmarks when DNA damage biology is tested in physiologically relevant 3D cancer models.
-
Ciprofloxacin hydrochloride: Assay Workflows
2026-08-16
Ciprofloxacin hydrochloride is a mechanistically defined fluoroquinolone antibiotic for bacterial DNA replication studies, susceptibility testing, and carefully controlled cell-based experiments. This guide translates its preparation, comparator value, and emerging antiparasitic relevance into practical workflows with troubleshooting checkpoints.
-
Puromycin aminonucleoside: Renal Model Workflows
2026-08-15
Puromycin aminonucleoside provides a practical bridge from controlled podocyte stress assays to proteinuria and glomerular pathology in animal studies. This workflow-focused guide covers stock handling, assay design, model selection, mechanistic extensions, and troubleshooting for reproducible renal injury research.
-
Lipo3K Transfection Reagent: Evidence & Workflow
2026-08-14
Lipo3K Transfection Reagent is a lipid transfection reagent for DNA, siRNA, and mRNA delivery across adherent, suspension, and difficult-to-transfect cells. Product information reports high efficiency, low cytotoxicity, serum compatibility, and a plasmid-specific Lipo3K-A enhancer, while independent peer-reviewed evidence cited here provides biological context rather than a direct Lipo3K performance benchmark.
-
Z-YVAD-FMK: Reliable Caspase-1 Assays
2026-08-14
Learn how Z-YVAD-FMK (SKU A8955) can help distinguish caspase-1-dependent pyroptosis from apoptosis, ferroptosis, and nonspecific viability loss. This scenario-driven guide covers assay compatibility, DMSO preparation, interpretation, and practical product-selection criteria.
-
Spiroplasma Entry into Drosophila S2 Cells
2026-08-13
The reference study establishes a Drosophila Schneider 2-cell model for Spiroplasma eriocheiris infection and shows that bacterial entry depends mainly on clathrin-mediated endocytosis and macropinocytosis. Its inhibitor-based experiments further connect intracellular infection with actin filament and microtubule integrity, providing a useful framework for dissecting host–pathogen interactions in invertebrate cells.
-
Dibutyryl-cAMP, Sodium Salt in Neuronal Assays
2026-08-13
Dibutyryl-cAMP, sodium salt provides a practical way to elevate intracellular cAMP while tracking PKA-linked signaling during neuronal conversion and nuclear remodeling. This guide connects DBcAMP sodium salt dosing, assay controls, and troubleshooting with the ASCL1–NUP37 findings reported in a 2026 transdifferentiation study.
-
AO/PI Staining Solution for Mechanistic Cell Counting
2026-08-12
Discover how AO/PI Staining Solution converts membrane integrity into a more reliable live/dead cell discrimination workflow for diabetic nephropathy research. This evidence-focused guide connects fluorescence-based cell counting with the mechanistic findings of a recent phillygenin study while defining what the assay can—and cannot—prove.
-
USP7–PKM2 Control of Macrophages in Pancreatitis
2026-08-12
The 2025 Cell Death and Disease study identifies USP7 as a metabolic regulator of macrophage polarization in severe acute pancreatitis by controlling PKM2 deubiquitination, phosphorylation, and nuclear localization. Its genetic and pharmacological experiments connect PKM2-dependent glycolytic reprogramming with pancreatic inflammation, while also defining important limits for translating this mechanism to oncology or other disease models.